{
  "trial_id": "NCT00362570",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "anaplastic oligodendroglioma or mixed oligoastrocytoma",
      "label": "not_met",
      "evidence": "Patient has anaplastic astrocytoma, not oligodendroglioma or mixed oligoastrocytoma."
    },
    {
      "criterion": "age > 18",
      "label": "met",
      "evidence": "Patient is a 45-year-old man."
    },
    {
      "criterion": "Karnofsky status > 70%",
      "label": "unknown",
      "evidence": "None mentioned in patient text."
    }
  ],
  "exclusion": [
    {
      "criterion": "prior chemotherapy or cranial irradiation",
      "label": "triggers",
      "evidence": "Patient received temozolomide and CPT-11 with Avastin, which is a form of chemotherapy. Additionally, patient underwent field radiation t10-l1."
    }
  ],
  "notes": "Karnofsky status unknown due to lack of information in patient text. Exclusion criteria likely triggers due to prior chemotherapy and cranial irradiation.",
  "_meta": {
    "topic_id": "1",
    "trial_id": "NCT00362570",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b"
  }
}